Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro (Q40176252)
Jump to navigation
Jump to search
scientific article published on February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro |
scientific article published on February 2007 |
Statements
1 reference
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro (English)
1 reference
Richard S Finn
1 reference
Charles Ginther
1 reference
Cindy A Wilson
1 reference
Padraic Glaspy
1 reference
Nishan Tchekmedyian
1 reference
Dennis J Slamon
1 reference
1 February 2007
1 reference
1 reference
105
1 reference
3
1 reference
319-326
1 reference
Identifiers
1 reference
1 reference